COCP (Cocrystal Pharma) Shiller PE Ratio: (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COCP Cocrystal Pharma Inc COCP
23 GF Score
Price $1.16
! 4 Warning Signs
View Full Analysis

What is Cocrystal Pharma Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cocrystal Pharma  (NAS:COCP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cocrystal Pharma Shiller PE Ratio Related Terms


Cocrystal Pharma Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Cocrystal Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cocrystal Pharma Shiller PE Ratio Chart

Cocrystal Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cocrystal Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

COCP vs AKTX, LGVN, NEUP: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Cocrystal Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cocrystal Pharma Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cocrystal Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cocrystal Pharma's Shiller PE Ratio falls into.


COCP
23GF Score
Cocrystal Pharma Inc COCP
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cocrystal Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cocrystal Pharma's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Cocrystal Pharma's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.23/333.9520*333.9520
=-0.230

Current CPI (Jun. 2026) = 333.9520.

Cocrystal Pharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -0.957 241.428 -1.324
201612 -34.522 241.432 -47.751
201703 -1.320 243.801 -1.808
201706 -0.480 244.955 -0.654
201709 -1.080 246.819 -1.461
201712 2.520 246.524 3.414
201803 -0.720 249.554 -0.964
201806 -0.600 251.989 -0.795
201809 -0.720 252.439 -0.952
201812 -18.960 251.233 -25.203
201903 1.200 254.202 1.576
201906 -0.600 256.143 -0.782
201909 -0.720 256.759 -0.936
201912 -18.000 256.974 -23.392
202003 -0.600 258.115 -0.776
202006 -0.840 257.797 -1.088
202009 -0.600 260.280 -0.770
202012 -0.120 260.474 -0.154
202103 -0.480 264.877 -0.605
202106 -0.480 271.696 -0.590
202109 -0.480 274.310 -0.584
202112 1.280 278.802 1.533
202203 -0.520 287.504 -0.604
202206 -3.000 296.311 -3.381
202209 -0.700 296.808 -0.788
202212 -0.540 296.797 -0.608
202303 -0.640 301.836 -0.708
202306 -0.410 305.109 -0.449
202309 -0.410 307.789 -0.445
202312 -0.440 306.746 -0.479
202403 -0.390 312.332 -0.417
202406 -0.530 314.175 -0.563
202409 -0.490 315.301 -0.519
202412 -0.320 315.605 -0.339
202503 -0.230 319.799 -0.240
202506 -0.200 322.561 -0.207
202509 -0.190 324.800 -0.195
202512 -0.170 324.054 -0.175
202603 -0.170 330.213 -0.172
202606 -0.230 333.952 -0.230

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cocrystal Pharma Business Description

Other Exchanges 8CC:Germany
Address 19805 North Creek Parkway, Bothell, WA, USA, 98011
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
23GF Score

Get the complete analysis for COCP

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.16
Price